Zheng Quan Ri Bao·2025-06-03 16:27Core Viewpoint - The Hong Kong IPO market has seen a significant revival in 2023, with total fundraising reaching HKD 77.36 billion as of June 3, 2025, driven by strong demand for new listings and favorable market conditions [1] Group 1: IPO Performance - CATL (宁德时代) leads the fundraising with HKD 41 billion, accounting for 53% of the total IPO amount this year [1] - A total of 28 new stocks have been listed this year, with a first-day failure rate of 53.57%, while the median first-day gain is 13.3%, significantly higher than that of Hong Kong Stock Connect companies [1] - The first-day performance of A-share companies listed in Hong Kong has been strong, with CATL rising 16.43%, and other companies like Hengrui Medicine and Jihong shares also showing notable gains [3] Group 2: Subscription Trends - The IPO market has experienced high oversubscription rates, with CATL's public offering seeing over 120 times subscription and Hengrui Medicine achieving 454.85 times [2] - The new tea drink brand Mixue Group achieved an extraordinary subscription rate of 5,324 times, indicating strong investor interest [2] - Ten new stocks have seen first-day gains exceeding 20%, with notable performances from companies like Yingen Biotechnology and Mixue Group [2] Group 3: Market Environment and Regulations - The Hong Kong Stock Exchange has implemented the FINI platform to shorten the time from pricing to trading from five business days to two, enhancing the IPO process [4][5] - The participation of retail investors remains high, but their success rate in winning allocations is generally below 10%, while institutional investors have a higher success rate [5][6] - Recent regulatory changes have shifted the allocation of shares, favoring institutional investors in the pricing process, which may lead to more efficient pricing and reduced volatility post-listing [6][7]